Endogenex, Inc.
Clinical trials sponsored by Endogenex, Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Electric zaps to the gut could help control type 2 diabetes Results expected Feb 2027 (estimated)
-
Could a gut lining 'Reset' help tame diabetes?
Disease control CompletedThis study tested a new device, DyaMX, that uses an endoscope to regenerate the lining of the upper small intestine in people with type 2 diabetes. The goal was to see if the procedure is safe and can help improve blood sugar control. 65 adults with diabetes took part. The main f…
Sponsor: Endogenex, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Electric pulses to the gut: a new hope for diabetes?
Disease control CompletedThis early study tested a device that uses mild electric pulses to regenerate the lining of the upper small intestine in 20 adults with type 2 diabetes. The goal was to see if the procedure is safe and could help lower blood sugar. Participants were on 2-3 diabetes pills and had …
Sponsor: Endogenex, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC